C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma

(NASDAQ:CCCC), WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that it has entered into a clinical trial collaboration and supply agreement with Pfizer Inc. Under the terms of the agreement, Pfizer will supply elranatamab (ELREXFIO(R)), a […]

Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination

(NasdaqGM:SGMT), Dosing has successfully commenced with healthy volunteers Primary endpoints for the Phase 1 trial include safety, tolerability, and pharmacokinetic (PK) profile of the combination Topline data are anticipated in the first half of 2026 SAN MATEO, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing

Finprime.pro Secures DASP License from El Salvador’s CNAD, Strengthening Commitment to Compliance and Security in Digital Assets

San Salvador, El Salvador, Oct. 01, 2025 (GLOBE NEWSWIRE) — Finprime.pro, a brand of Digital Trading Group of Central America S.A. DE C.V., a next-generation crypto broker dedicated to providing secure and transparent access to digital assets, today announced that the group have been granted additional license as Digital Asset Service Provider (DASP) license by

Black Diamond Group Limited Announces Timing for Third Quarter 2025 Financial Results and Conference Call

(TSX:BDI),(OTC US:BDIMF),(Other OTC:BDIMF), CALGARY, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) — Black Diamond Group Limited (“Black Diamond” or the “Company”) (TSX: BDI, OTCQX:BDIMF), a leading provider of space rental and workforce accommodation solutions, today announces the timing of its 2025 third quarter earnings release and conference call/webcast. Black Diamond intends to release its 2025 third

Close-Up International Selected by VS Health Group to Deliver Market Access Business Intelligence CRM Solution

PRINCETON, N.J., Oct. 01, 2025 (GLOBE NEWSWIRE) — Close-Up Intl, a global leader in AI-powered CRM market data and business intelligence solutions for the pharmaceutical industry, announced it has been selected by VS Health Group (Viking Payer) as its CRM partner to support the company's expanding Market Access and Payer Engagement teams. Close-Up, a pioneer

Baker Hughes to Supply Liquefaction Train Equipment for Sempra Infrastructure’s Port Arthur LNG Phase 2 Project

(NASDAQ:BKR), Contract awarded by Bechtel to supply primary liquefaction equipment for two trains, including four Frame 7 gas turbines and eight centrifugal compressors Baker Hughes will also provide two motor-driven compressors for the plant's booster services Technology solution supports a nameplate capacity of approximately 13 million tonnes per annum (MTPA) HOUSTON and LONDON, Oct. 01,

Climb Channel Solutions Launches North American Partnership with Binary Defense to Deliver Attacker-Minded MDR Solutions

(NasdaqGM:CLMB), EATONTOWN, N.J., Oct. 01, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB)… today announced a strategic partnership with Binary Defense, a leading Managed Detection and Response (MDR) provider. This collaboration brings Binary Defense's attacker-minded security solutions to Climb's expansive

High Bar Brands expands Panelite portfolio with launch of Elite and Select subbrands

OWATONNA, Minn., Oct. 01, 2025 (GLOBE NEWSWIRE) — High Bar Brands (HBB), parent company of Panelite, today announced the launch of two new stainless steel subbrands – Elite and Select – designed to deliver greater choice, flexibility, and value to the heavy-duty aftermarket. The new Elite line features premium 304 stainless steel, renowned for its

Accumulus Synergy Appoints Khushboo Sharma as Chief Executive Officer

BURLINGAME, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) — Accumulus Synergy today announced that its Board of Directors has appointed Khushboo Sharma as Chief Executive Officer, effective immediately. Ms. Sharma, who has served as the association's Chief Regulatory Innovation Officer since 2022, succeeds Francisco Nogueira, who will now focus exclusively on leading Accumulus Technologies, the commercial

Neumora Therapeutics to Host Virtual R&D Day on October 27

(NASDAQ:NMRA), WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will host a virtual R&D Day on Monday, October 27,

Scroll to Top